Rovin Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $493K | Buy |
5,405
+579
| +12% | +$52.8K | 0.15% | 111 |
|
|
2025
Q1 | $546K | Sell |
4,826
-143
| -3% | -$16.2K | 0.18% | 93 |
|
|
2024
Q4 | $525K | Sell |
4,969
-1,457
| -23% | -$154K | 0.19% | 94 |
|
|
2024
Q3 | $694K | Buy |
6,426
+1,029
| +19% | +$111K | 0.26% | 87 |
|
|
2024
Q2 | $586K | Buy |
5,397
+645
| +14% | +$70K | 0.24% | 83 |
|
|
2024
Q1 | $627K | Buy |
4,752
+737
| +18% | +$97.2K | 0.26% | 79 |
|
|
2023
Q4 | $489K | Buy |
4,015
+779
| +24% | +$94.9K | 0.22% | 87 |
|
|
2023
Q3 | $363K | Sell |
3,236
-286
| -8% | -$32.1K | 0.17% | 90 |
|
|
2023
Q2 | $513K | Sell |
3,522
-126
| -3% | -$18.4K | 0.23% | 69 |
|
|
2023
Q1 | $471K | Sell |
3,648
-535
| -13% | -$69.1K | 0.22% | 75 |
|
|
2022
Q4 | $533K | Sell |
4,183
-194
| -4% | -$24.7K | 0.27% | 62 |
|
|
2022
Q3 | $458K | Sell |
4,377
-152
| -3% | -$15.9K | 0.26% | 65 |
|
|
2022
Q2 | $476K | Buy |
4,529
+67
| +2% | +$7.04K | 0.32% | 62 |
|
|
2022
Q1 | $571K | Buy |
4,462
+673
| +18% | +$86.1K | 0.3% | 55 |
|
|
2021
Q4 | $467K | Buy |
+3,789
| New | +$467K | 0.22% | 72 |
|